Skip to main content
Year archive

ANGLE PLC — 2020 filings

All 43 regulatory filings released by ANGLE PLC (AGL) in 2020, sourced directly from the official regulator.

43 Filings
2020 Period
2020 filings (43)
Filing Released Lang
Parsortix can capture single cancer cell in sample
Regulatory Filings
2020-12-09 English
Holding(s) in Company
Major Shareholding Notification
2020-11-20 English
Holding(s) in Company
Major Shareholding Notification
2020-11-18 English
Result of General Meeting
AGM Information
2020-11-13 English
Director/PDMR Shareholding
Director's Dealing
2020-11-03 English
Interim Results
Interim / Quarterly Report H1 2020
2020-10-29 English
Result of Placing & Notice of General Meeting
Declaration of Voting Results & Voting Rights Announcements
2020-10-27 English
Accelerated bookbuild to raise up to £20m
Capital/Financing Update
2020-10-27 English
Submission accepted by FDA for substantive review
Legal Proceedings Report
2020-10-20 English
Issue of LTIP Options and Share Options
Remuneration Information
2020-09-28 English
ANGLE announces completion of FDA submission
Regulatory Filings
2020-09-28 English
Potential treatment strategy to limit metastasis
Regulatory Filings
2020-09-23 English
Holding(s) in Company
Major Shareholding Notification
2020-09-11 English
Holding(s) in Company
Major Shareholding Notification
2020-09-11 English
Notification of Interim Results and Webcast
Report Publication Announcement
2020-09-02 English
Holding(s) in Company
Major Shareholding Notification
2020-09-02 English
Result of 2020 Annual General Meeting
AGM Information
2020-08-27 English
Holding(s) in Company
Major Shareholding Notification
2020-08-18 English
Parsortix use to assess response to immunotherapy
Regulatory Filings
2020-08-14 English
Holding(s) in Company
Major Shareholding Notification
2020-08-06 English
Notice of AGM and Posting of Annual Report
Report Publication Announcement
2020-08-05 English
Study: Parsortix use in metastatic breast cancer
Environmental & Social Information
2020-07-20 English
Holding(s) in Company
Major Shareholding Notification
2020-07-08 English
Holding(s) in Company
Major Shareholding Notification
2020-07-08 English
Holding(s) in Company
Major Shareholding Notification
2020-07-08 English
Preliminary Results
Earnings Release FY 2019
2020-06-25 English
Blood donations recommenced for FDA studies
Earnings Release Q2 2020
2020-06-22 English
Notice of Results
Report Publication Announcement
2020-05-29 English
CTC potential as biomarker in MET inhibitor trials
Environmental & Social Information
2020-05-12 English
Leading cancer centre publishes Parsortix workflow
Regulatory Filings
2020-05-04 English
Business Update
Regulatory Filings
2020-04-28 English
Parsortix performance in head and neck cancer
Environmental & Social Information
2020-04-17 English
COVID-19 BUSINESS IMPACT UPDATE
Regulatory Filings
2020-03-31 English
Assessing risk of brain metastasis in lung cancer
Environmental & Social Information
2020-03-03 English
Parsortix outperforms other CTC systems in RCC
Regulatory Filings
2020-02-27 English
ANGLE announce Tri-Con presentation with BioView
Earnings Release Q1 2020
2020-02-25 English
Data demonstrates key advantages of Parsortix
Regulatory Filings
2020-02-17 English
Study demonstrates Parsortix potential in melanoma
Regulatory Filings
2020-02-11 English
Issue of Equity
Share Issue/Capital Change
2020-02-03 English
Interim Results
Earnings Release H1 2019
2020-01-30 English
Change of accounting reference date
Report Publication Announcement
2020-01-30 English
Successful face-to-face meeting with FDA
Legal Proceedings Report
2020-01-22 English
Notice of Results
Report Publication Announcement
2020-01-08 English